M. L. Aubert

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism

T. Pedrazzini, M. Aubert, D. Pierroz, 2001, Molecular and Cellular Endocrinology.

Pituitary receptor sites for gonadotropin-releasing hormone: effect of castration and substitutive therapy with sex steroids in the male rat.

B. Conne, M. Aubert, P. Sizonenko, 1982, Endocrinology.

Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix.

Jean E Rivier, J. Rivier, P. Conn, 2002, The Journal of pharmacology and experimental therapeutics.

GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6.

J. Rivier, M. Aubert, P. Rivière, 2001, Journal of medicinal chemistry.

Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.

V. d’Allèves, P. D. Raposinho, P. Broqua, 2000, Endocrinology.

Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.

M. Aubert, D. Pierroz, J. Rivier, 1996, Endocrinology.

Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat.

M. Aubert, D. Pierroz, N. Gruaz, 1995, Neuroendocrinology.